
Über
CatalYm develops antibodies that will neutralize the tumor-produced immune suppressant GDF-15 to increase immune cell infiltration into the tumor microenvironment, which can also potentiate the activity of (approved) checkpoint-blockers in fighting the tumor.
Schwerpunkte
["mobility"]
Region
📍 Ansässig in Berlin
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...